Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3901551
Max Phase: Preclinical
Molecular Formula: C23H24ClN5O3S
Molecular Weight: 486.00
Molecule Type: Small molecule
Associated Items:
ID: ALA3901551
Max Phase: Preclinical
Molecular Formula: C23H24ClN5O3S
Molecular Weight: 486.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)OC(=O)CCNC(=O)Nc1nc2c(s1)-c1nc(-c3ccccc3Cl)ncc1CC2
Standard InChI: InChI=1S/C23H24ClN5O3S/c1-23(2,3)32-17(30)10-11-25-21(31)29-22-27-16-9-8-13-12-26-20(28-18(13)19(16)33-22)14-6-4-5-7-15(14)24/h4-7,12H,8-11H2,1-3H3,(H2,25,27,29,31)
Standard InChI Key: CCBWBGMWGKJQOG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 486.00 | Molecular Weight (Monoisotopic): 485.1288 | AlogP: 4.87 | #Rotatable Bonds: 5 |
Polar Surface Area: 106.10 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.81 | CX Basic pKa: 0.37 | CX LogP: 4.65 | CX LogD: 4.51 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.50 | Np Likeness Score: -1.64 |
1. Mejdrová I, Chalupská D, Plačková P, Müller C, Šála M, Klíma M, Baumlová A, Hřebabecký H, Procházková E, Dejmek M, Strunin D, Weber J, Lee G, Matoušová M, Mertlíková-Kaiserová H, Ziebuhr J, Birkus G, Boura E, Nencka R.. (2017) Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology., 60 (1): [PMID:28004945] [10.1021/acs.jmedchem.6b01465] |
Source(1):